首页|半夏白术天麻汤加减联合替罗非班治疗风痰瘀阻型急性缺血性卒中的临床疗效观察

半夏白术天麻汤加减联合替罗非班治疗风痰瘀阻型急性缺血性卒中的临床疗效观察

扫码查看
目的 研究旨在评估半夏白术天麻汤加减联合替罗非班治疗风痰瘀阻型急性缺血性卒中的临床疗效。方法 选取 2022 年 6月~2023 年 6 月符合纳入标准的急性脑梗死患者 100 例,按随机数字表的方式分为治疗组、对照组,各 50 例。两组均予以常规西医治疗,对照组加替罗非班治疗,治疗组在对照组的基础上加用半夏白术天麻汤加减治疗。连续治疗 14 d。比较治疗前后两组患者的临床疗效、中医证候积分、美国国立卫生研究院卒中量表(NIHSS)评分、功能独立性评测量表(FIM)评分、改良运动功能评分(mRS)及相关血液指标[超敏-C反应蛋白(hs-CRP)、凝血指标、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)]水平。结果 治疗组患者总有效率高于对照组(P<0。05),与治疗前相比,治疗后两组患者NIHSS评分、MRS评分、FIM评分、中医证候积分及相关血液学指标水平均改善(P<0。05),且治疗组患者上述指标改善情况均显著优于对照组(P<0。05)。结论 与单纯西医治疗相比,半夏白术天麻汤加减联合替罗非班对风痰瘀阻证的急性缺血性卒中治疗效果更佳,能明显改善神经功能,提高患者的生活质量,对中医证候的缓解效果更佳。
Clinical efficacy observation of Modified Banxia Baizhu Tianma Decoction combined with tirofiban in the treatment of acute ischemic stroke with wind-phlegm stasis type
Objective The aim of the study is to evaluate the clinical efficacy of the addition and subtraction of Modified Banxia Baizhu Tianma Decoction combined with tirofiban in the treatment of acute ischemic stroke of wind-phlegm stasis type.Methods 100 patients were screened to meet the inclusion criteria,and were randomly divided into the treatment group and the control group,50 cases each group.The control group was treated with conventional western medicine and intravenous pumping of tirofiban.The observation group was treated with the addition of Modified Banxia Baizhu Tianma Decoction on the basis of the control group.Each group was treated for 14 days.The clinical efficacy,TCM syndrome points scale,NIHSS score,Functional Independence Measurement Scale(FIM),Modified Motor Function Score(mRS),and the levels of related blood indexes[ultrasensitive C-Reactive Protein(hs-CRP),coagulation indexes,Interleukin-6(IL-6),Tumor Necrosis Factor-α(TNF-α),superoxide dismutase(SOD),glutathione peroxidase(GSH-Px)]were compared between the two groups before and after treatment.Results The total effective rate of the treatment group was higher than that of control group(P<0.05).After treatment,the NIHSS scores,MRS scores,FIM scores,as well as the TCM evidence scores,and the levels of relevant hematological indexes improved in both groups(P<0.05),and the improvement of the above indexes in the treatment group was significantly better than that of the control group(P<0.05).Conclusion Compared with Western medical treatment alone,the combination of Modified Banxia Baizhu Tianma Decoction and tirofiban is more effective in treating acute ischemic stroke with wind-phlegm and phlegm stasis obstruction,which can significantly improve neurological function and quality of life,and is more effective in alleviating the effects of traditional Chinese medicine(TCM)syndromes.

Modified Banxia Baizhu Tianma DecoctionTirofibanWind phlegm and stasisAcute ischemic stroke

牛小华、吴云虎

展开 >

安徽中医药大学第一附属医院,合肥 230000

安徽中医药大学第一附属医院脑血管介入科,合肥 230000

半夏白术天麻汤加减 替罗非班 风痰瘀阻 急性缺血性卒中

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(2)
  • 19